Consonance Capital Partners

Private Capital for Healthcare
in the Middle Market

Consonance Capital Partners (“CCP”) is a private equity manager focused exclusively on investing in the healthcare industry. CCP’s founders, Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle, partnered together for over a decade while at JPMorgan Partners and its successor and predecessor entities (collectively “JPMP”), and have over 90 years of combined experience in private equity investing, primarily within healthcare. To date, CCP has raised over $1.3 billion in equity capital across two funds, and CCP is currently investing out of Consonance Private Equity II, L.P. With a history of successfully investing across multiple healthcare sub-sectors, Consonance Capital Partners brings a wealth of experience, insights, and an extensive network of relationships to existing and prospective management teams and portfolio companies.

 
Abstract%20art%20creative%20background.%

Investment Strategy

Consonance Capital Partners (“CCP”) looks to invest in U.S. middle market companies that add sustainable value to the healthcare system by facilitating the delivery of higher quality care at a lower cost. The firm leverages its vast network and experience in the healthcare industry to proactively identify high growth industry subsectors, proven business models in emerging subsectors, and platform opportunities in unconsolidated subsectors. The team at CCP then systematically pursues opportunities within this framework that meet its core investment criteria.


Key to the process is the identification of world-class management teams who have a demonstrated ability to effectively navigate a highly complex and regulated industry. CCP deeply values these partnerships and believes that strong operators with aligned incentives are the backbone of a successful investment strategy.


Currently investing out of Consonance Private Equity II, L.P., CCP targets growth equity, leveraged buyouts, and recapitalization transactions in the middle market. Target companies generally have between $25 million and $500 million in revenues. The sources of these opportunities are typically derived from private/family-owned businesses seeking liquidity, growth capital, or both – and large corporations seeking to divest non-core assets. CCP brings more than just capital to management teams by leveraging its relationships and resources to drive internal growth initiatives, operational improvements, and mergers & acquisitions.

 

Strategic Partners

CCP seeks to partner with world-class management teams in subsectors that have high growth opportunities. The firm takes a collaborative approach to these relationships and believes that strong managers with aligned incentives are the backbone of a successful investment strategy. In addition, CCP has a robust history of working together with large corporations which are seeking to divest non-core assets and private/family-owned businesses which are seeking liquidity, growth capital, or both from knowledgeable, experienced, and partner-oriented healthcare investors.

 

With health care investing experience extending over 30 years and across numerous economic cycles, the team has broad experience across multiple sub-sectors, including:

Providers

Payors

Diagnostics

Distribution

Devices

Specialty Pharmaceuticals

Outsourced Services

(Payor, Provider,

Pharma, etc.)

Healthcare IT